Dec 1, 2022, 09:34 AM by

Dec 1, 2022, 09:33 AM by

Dec 1, 2022, 09:26 AM by

VisualDx has teamed up with Emergence Health Holdings, an urgent care network across New England, to grant its providers access to AI-fueled assistive technology to support diagnosis and treatment. Amid concurrent crises, staff shortages, and other challenges in medicine, VisualDx is collaborating with an array of organizations to arm clinicians with tech that helps them do their jobs better, faster, and more accurately. In addition to Emergence, the company also recently teamed up with the Vermont Department of Health, HHS’s Biomedical Advanced Research and Development Authority, and the American College of Emergency Physicians to help clinicians diagnose and treat everything from Covid to Monkeypox, polio, the flu, and more.

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:27 AM by

Genezen appoints Jeff Whitmore as Chief Commercial Officer

Nov 30, 2022, 09:27 AM by

Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.

Nov 30, 2022, 01:00 AM by User Not Found

Bio-IT World | An artificial intelligence-based framework that assesses the effectiveness of novel cancer therapies in real time; three new AI-rare disease partnerships; a cross-border federated network of national genome collections for biomedical research and personalized medicine solutions; multi-scale precision cardiology platforms and heart-on-a-chip technology aimed at developing the infrastructure for a digital replica of an individual’s heart; and more.

Nov 29, 2022, 09:32 AM by

Nov 29, 2022, 09:32 AM by

Nov 29, 2022, 09:31 AM by

Nov 29, 2022, 09:31 AM by

Nov 29, 2022, 01:00 AM by User Not Found

Bio-IT World | Funding for first-in-class peptide-drug conjugate for tumor cells, gene delivery research and development, next-generation orthopedic products, and more.

Nov 28, 2022, 15:39 PM by

Eloi brings more than 30 years of life science leadership experience to Vaxess’ board; will advise company as it moves towards commercialization of MIMIX vaccine patch

Nov 28, 2022, 15:39 PM by

Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.

Nov 28, 2022, 15:38 PM by

Flywheel is creating a federated data network aimed at improving AI for breast imaging—on a scale not previously possible.

Nov 28, 2022, 15:38 PM by

Nov 28, 2022, 15:37 PM by

Nov 28, 2022, 15:37 PM by